We develop phytotherapeutic products as adjuvants in the treatment of respiratory diseases such as COVID-19, breast cancer, and Acute Myeloid Leukemia. We have the first transfer option of the products derived from the GAT (Colombia Científica) ecosystem financed by the World Bank and led by the Javeriana University.

Dreembio initial products

info@dreembio.com

gestion@dreembio.com

3006595050

Bogotá, Colombia

Follow us on social media: